BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29683461)

  • 21. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteasome activity is required for the initiation of precancerous pancreatic lesions.
    Furuyama T; Tanaka S; Shimada S; Akiyama Y; Matsumura S; Mitsunori Y; Aihara A; Ban D; Ochiai T; Kudo A; Fukamachi H; Arii S; Kawaguchi Y; Tanabe M
    Sci Rep; 2016 May; 6():27044. PubMed ID: 27244456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mouse models for human colorectal cancer with liver metastasis].
    Huang XD; Zheng YB; Yang YJ; Yang C; Li HL; Cheng HR
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2701-2705. PubMed ID: 31505723
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer.
    Griesmann H; Drexel C; Milosevic N; Sipos B; Rosendahl J; Gress TM; Michl P
    Gut; 2017 Jul; 66(7):1278-1285. PubMed ID: 27013602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
    Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer.
    Zhong Y; Macgregor-Das A; Saunders T; Whittle MC; Makohon-Moore A; Kohutek ZA; Poling J; Herbst BT; Javier BM; Cope L; Leach SD; Hingorani SR; Iacobuzio-Donahue CA
    Clin Cancer Res; 2017 Mar; 23(6):1607-1620. PubMed ID: 27637888
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI Radiomics: A Preliminary Investigation.
    Eresen A; Yang J; Shangguan J; Benson AB; Yaghmai V; Zhang Z
    Acad Radiol; 2021 Jun; 28(6):e147-e154. PubMed ID: 32499156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of murine pancreatic tumors by high-resolution ultrasound.
    Sastra SA; Olive KP
    Methods Mol Biol; 2013; 980():249-66. PubMed ID: 23359158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of dimethylaminoparthenolide and sulindac in combination with gemcitabine in a genetically engineered mouse model of pancreatic cancer.
    Yip-Schneider MT; Wu H; Hruban RH; Lowy AM; Crooks PA; Schmidt CM
    Pancreas; 2013 Jan; 42(1):160-7. PubMed ID: 22699205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically engineered mouse models of pancreatic cancer.
    Westphalen CB; Olive KP
    Cancer J; 2012; 18(6):502-10. PubMed ID: 23187836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer.
    Ma L; Saiyin H
    PLoS One; 2017; 12(5):e0176844. PubMed ID: 28475592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/miR-217 host gene is embryonic lethal.
    Azevedo-Pouly AC; Sutaria DS; Jiang J; Elgamal OA; Amari F; Allard D; Grippo PJ; Coppola V; Schmittgen TD
    Funct Integr Genomics; 2017 May; 17(2-3):203-212. PubMed ID: 27541609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation Of Wild-Type Hras Suppresses The Earliest Stages Of Pancreatic Cancer.
    Weyandt J
    Redox Biol; 2015 Aug; 5():414. PubMed ID: 28162272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
    Mace TA; Shakya R; Pitarresi JR; Swanson B; McQuinn CW; Loftus S; Nordquist E; Cruz-Monserrate Z; Yu L; Young G; Zhong X; Zimmers TA; Ostrowski MC; Ludwig T; Bloomston M; Bekaii-Saab T; Lesinski GB
    Gut; 2018 Feb; 67(2):320-332. PubMed ID: 27797936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1/Cre mouse model of pancreatic cancer.
    Lanza-Jacoby S; Yan G; Radice G; LePhong C; Baliff J; Hess R
    Exp Biol Med (Maywood); 2013 Jul; 238(7):787-97. PubMed ID: 23828595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasensitive MRI detection of spontaneous pancreatic tumors with nanocage-based targeted contrast agent.
    Kawano T; Murata M; Kang JH; Piao JS; Narahara S; Hyodo F; Hamano N; Guo J; Oguri S; Ohuchida K; Hashizume M
    Biomaterials; 2018 Jan; 152():37-46. PubMed ID: 29107217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
    Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
    Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.